News

Siamab Therapeutics Presents New PreClinical Safety Data

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced the presentation of new preclinical data demonstrating the safety of its novel anti-Sialyl-Tn (STn) antibody drug conjugates (ADCs) in multiple animal models, including non-human primates (NHPs). These results add to the company’s efficacy data findings showing that its anti-STn antibody therapeutics inhibit tumor progression in cell-line-derived and patient-derived xenograft (PDX) ovarian cancer and pancreatic cancer mouse models, with complete regression observed in some treatment arms. The preclinical efficacy...
Read more...

Regroup to Host Live Webinar on Active Shooter Preparedness for Large Venues and High Rises

Regroup Mass Notification, the award-winning leader in emergency and day-to-day communication technology, today announced a joint alliance with Alvarez Associates, industry leader in workplace violence prevention, to present an online webinar on critical strategies for preparing for and responding to active shooter events at large venues. Read more >>
Read more...

Helping The Blind To See

“eSight 3 is a game-changer for the legally blind. My entire career has been spent engineering sight-enabling technologies, so I can say with some authority that eSight’s world-class lab is the largest and best engineering team, anywhere in the world, that specializes exclusively in developing medical devices that allow the legally blind to actually see and be mobile,” the company say. Read more >>
Read more...